Suicide Prevention Month: Part I

September is National Suicide Prevention Month. To bring additional attention to this important public health issue, this month we will highlight at risk populations in Arizona and simple steps we can all take to decrease suicides.

by Kelli Donley Williams

The largest group of individuals who die of suicide in Arizona are white men, 65 and older, who live in rural communities. They often have alcohol in their systems at time of death. They most often die by firearm.

What to do with this information? Suicide ideation happens when the brain is not functioning properly. It is a temporary, while critical period of time. This time can become more difficult if the individual is taking drugs or alcohol, especially depressants.

If you have someone in your life who is behaving in a concerning manner, discussing suicide, or abusing drugs or alcohol, the life-saving step to take is to sit him or her down for a private conversation and ask if there is a suicide plan in place. If there is, it is appropriate to call 9-88 and ask for a behavioral health crisis team. The key information here not to let this person out of your sight until he or she is transferred into the care of a medical professional, not even to use a restroom.

If the person says there isn’t a suicide plan in place, there are still steps you can take to help. Ask if there are firearms in the home. If there are, ask to remove them. Also consider removing alcohol or other depressants and see that the person has someone checking in regularly. (Ideally multiple times a day.)

It can be scary to discuss suicide. It is a tough conversation, and one where both parties must be vulnerable. But it is also a courageous conversation and one we encourage you to have if you have any concerns.

For more information, consider calling 9-88, or chat online with someone for advice: www.crisistextline.org

HHS Recommends Cannabis be Moved to Schedule III

HHS is recommending that the Drug Enforcement Agency significantly loosen federal restrictions on marijuana but continues to recommend that it still be on the Controlled Substances Act list. HHS wants the drug moved from Schedule I to Schedule III under the CSA, potentially the biggest change in federal drug policy in decades.

The HHS letter is part of the official review process initiated by President Joe Biden last October: The FDA conducts the review, which is then sent to the National Institute on Drug Abuse and HHS, after which HHS transmits a letter to the DEA, who makes the final call.

AzPHA Annual Awards Event October 26: Register to Attend & Nominate Your Colleagues for an Award!

Thursday, October 26, 2023

5:00pm – 8:30pm

Outdoor Courtyard at the Maricopa Medical Society
326 E Coronado Rd #101, Phoenix, AZ 85004

Tickets are only $60 and includes a full taco bar from Senor Taco with protein taco fillings plus beans, rice, guacamole, chips, tortillas & additional pre-rolled tacos.

Hosted Bar service by Top Shelf Bartenders includes wine, beer and soft drinks.

Register Today

_________________________

Please take a moment to nominate colleagues here by September 15!

Upcoming Arizona State Hospital Events, Reports, & Deadlines

Members of the legislature, stakeholders and especially family members with loved ones at the ADHS’ Arizona State Hospital became increasingly frustrated with the lack of transparency at the Hospital during the directorships of Christ & Herrington. ADHS leadership’s refusal to participate in the Arizona State Hospital Independent Oversight Committee (IOC) meetings (or provide the committee information) compelled the legislature to pass SB1444 directing the agency to actually attend IOC meetings, respond to requests for information, and to develop several reports.

From the AZ Legislative Council’s analysis:

SB1444 prohibits administration and employees of the Arizona State Hospital (ASH) from retaliating against a patient due to family participation in Arizona State Hospital Independent Oversight Committee (ASH-IOC) meetings and requires the ASH Superintendent and Chief Medical Officer to attend and participate in meetings. Directs ASH administration to develop and implement an innovative clinical improvement and human resources development plan. 

Here’s a summary of the upcoming reports and events mandated by SB1444 for the: 1) Independent Oversight Committee; 2) Arizona State Hospital’s Clinical Improvement and HR Development Plan; and 3) Joint Legislative Psychiatric Review Council:

 

The Arizona State Hospital Independent Oversight Committee has been meeting monthly. Now that ASH executives are compelled by law to participate, the meetings are more substantive (prior to the passage of SB1444 ASH & ADHS leadership refused to attend the IOC). The next ASH IOC meeting is on September 21 (starting at 6pm). You can listen to the August meeting here. Meetings are open to the public: ADHS Arizona State Hospital Independent Oversight Committee.

The main responsibilities of the IOC include:

  1. Ensuring that the rights of clients are protected;
  2. Reviewing incidents of possible abuse, neglect, or denial of an ASH client’s rights;
  3. Making recommendations to the director of any department and service provider regarding laws, rules, policies, procedures, and practices to ensure the protection of the rights of clients receiving behavioral health and developmental disability services;
  4. Submitting written objections to specific problems or violations of client rights by the department or service provider through the director of the department of administration for review by the ADHS Director;
  5. Delivering to the committee a detailed written response to each written objection within 21 days after receiving the objection from the department of administration; and
  6. Issuing an annual report of its activities and recommendations to Director Cunico, and the Directors of AHCCCS and ADES as well as the legislature and governor.

Interestingly, the last IOC Committee Annual Report was from 2021 – but that’s probably because, prior to SB1444 becoming effective, ADHS was boycotting the meetings and not responding to the IOC’s requests for information.

 

Arizona State Hospital’s Clinical Improvement and HR Development Plan is due to the governor, legislative leadership and the Health and Human Services committee chairs by September 1, 2023. That directive is in the Session Law part of SB1444 (on the bottom of page 4)

The report is supposed to provide “an evidence-based and innovative clinical improvement and human resources development plan and proposed budget to fully implement the plan. You can see the details in that session law section for the components it’s supposed to have at the bottom of page 4.

Friday’s report is supposed to:

  • Identify necessary enhancements to ASH services, facilities, and staff to provide statutorily required treatment and services to patients in each division, including treatment and services for secondary diagnoses;
  • Provide options and recommendations to reduce the number of patients statewide who are seeking admission to ASH and to reduce the wait time for admission;
  • Identify optimal levels of acuity-based staffing with full-time employees and minimal use of contract staff as well as ways to increase the number of forensically trained clinical staff;
  • Identify levels of service that assist in transitioning patients from ASH into clinically appropriate settings as well as ways to increase the number of patients that have transitioned into the community without readmission to ASH or another facility; and
  • Identify an independent third party, residing outside of Arizona, to investigate incident reports and to receive complaints from patients, families, and advocates.

 

The Joint Legislative Psychiatric Hospital Review Council is supposed to produce a report on or before December 31, 2023, with their recommendations to the speaker of the house of representatives, the president of the senate and the governor.  This Council isn’t solely focused on the state hospital but does include elements related to ASH.

That report (also required by SB1444 and written by the Joint Legislative Psychiatric Hospital Review Council) is supposed to examine:

  1. The feasibility of transferring ASH to AHCCCS or an alternative oversight entity.
  2. Psychiatric hospital capacity in this state, including the bed capacity at the Arizona State Hospital and other public facilities;
  3. The role of private facilities in addressing psychiatric treatment needs;
  4. Innovative programs to ensure public safety while providing clinically appropriate treatment in the most integrated setting;
  5. Legal barriers;
  6. Current waiting lists;
  7. Barriers to accessing appropriate inpatient care;
  8. Licensing barriers; and
  9. Any other issues related to inpatient psychiatric treatment.

Let’s cross our fingers that these reports are substantive, that the Department provides the required information to the IOC, and that policymakers translate the report information and IOC findings into actionable policies that improve care at the Hospital. Time will tell.

HHS Names 1st 10 Drugs Up for Negotiation Under Medicare

This Reform is Welcome – but Far from the Transformative Change Needed to Keep the Medicare Trust Fund Solvent

For the last 20 years, all Americans have been getting ripped off by pharmaceutical companies. The heist began when a prescription drug benefit was added for Medicare enrollees (Medicare Part D). Drug company lobbyists made sure Congress wrote the law to prohibit Medicare from negotiating drug prices.

As a result, Medicare is held hostage by drug companies and Medicare pays 300% more for prescription drugs than in Europe or Canada, and close to 10x higher than in developing nations. That means every American who gets a paycheck is paying way more than necessary for prescription drugs. We’re ALL being scammed (not just Medicare beneficiaries) because Medicare is financed with a (regressive) payroll tax.

The Inflation Reduction Act of 2022 finally included modest reform by allowing Medicare to begin negotiating the price of a handful (initially 10) of the thousands of drugs they cover in Medicare Part D.

No doubt you’ve heard politicians and even some stakeholders praise the legislation as historic and transformative when it comes to prescription drug price reform. It’s fair to say the Act is historic because Medicare is finally able to negotiate the price of a handful of drugs (for implementation in 2026).

But the bill IS NOT Transformative. While Medicare is now about to negotiate the prices – they’re limited to negotiating price of just 10 drugs starting this year for implementation in 2026. The next year (2027) they can negotiate the price of 15 more.

By contrast, the drug price reduction passed by the House of Representatives (H.R. 3, the Lower Drug Costs Now Act of 2019) would have allowed Medicare to negotiate the price of between 25-125 brand-name drugs without generic competitors in 2023 with the negotiated price available Medicare, Medicaid & private payers.

See: ‘Inflation Reduction Act of 2022’ Gets a C- for Cutting Prescription Drug Prices

The drug pricing reforms in the Inflation Reduction Act of 2022 are anemic. With a little more backbone, we could have had real price reform. As it is, it’s like bringing home a C- on your report card. Congress still gets credit for the class, but it’s nothing to brag about.

Today the US Department of Health & Human Services announced the first 10 drugs that they will negotiate with the manufacturers – with the new prices finally going into effect in 2026.

Factsheet: Medicare Drug Price Negotiation Program

Below is the list of 10 drugs covered under Medicare Part D selected for negotiation for initial price applicability year 2026, based on total gross covered prescription drug costs under Medicare Part D and other criteria as required by the law. For example, any drug that was approved by the FDA less than 7 years ago can’t be negotiated.

 

Drug                     Condition                                                       Part D Cost $               # of Part D Users

Eliquis                  Prevention &treatment of blood clots            $16,482,621,000                  3,706,000

Jardiance             Diabetes; Heart failure                                   $7,057,707,000                   1,573,000

Xarelto                 Prevention / treatment of blood clots             $6,031,393,000                   1,337,000

Januvia                Diabetes                                                         $4,087,081,000                     869,000

Farxiga                Diabetes; Heart failure                                    $3,268,329,000                     799,000

Entresto               Heart failure                                                    $2,884,877,000                     587,000

Enbrel                  Rheumatoid arthritis                                       $2,791,105,000                       48,000

Imbruvica            Blood cancers                                                 $2,663,560,000                        20,000

Stelara                Psoriasis; Ulcerative colitis                            $2,638,929,000                         22,000

Fiasp et.al.          Diabetes                                                         $2,576,586,000                       777,000

According to the HHS, the list of drugs above represents: “… the 10 drugs with the highest total Part D gross covered prescription drug costs after excluding from the ranked list of 50 negotiation eligible drugs any biologics that qualify for delayed selection as a result of there being a high likelihood that a biosimilar will enter the market within a specified time.”

Over the next 4 years, Medicare will negotiate prices for up to 60 drugs covered under Medicare Part D and Part B, and up to an additional 20 drugs every year after that.

I’m delighted that Medicare can finally actually negotiate the price of at least a few drugs, but quite honestly, I find it hard to be a cheerleader for such a tepid reform when transformative change is needed.

Member Profile: Diane Wasley

by Kelli Donley Williams / Diane Wasley

I had the chance to meet Diane several years ago. She reached out to Will before an annual conference to see if someone would be her “buddy.” She was studying public health at NAU and wanted to attend and learn, but she is autistic and knew she’d be overwhelmed in the crowd. Diane is shy, and at times struggles to make decisions. She is also very bright and passionate about public health. Walking through the conference with a friend would make the experience easier.

This was the beginning of our friendship. Since, Diane and I have attended a handful of conferences and other events together. My husband and I were in Flagstaff in May to watch Diane walk across the stage to receive her bachelor’s in public health. We screamed as loud as we could in the busy stadium to show our support, but our voices (and my tears) couldn’t capture the pride we felt for her.

Graduation was just one milestone Diane has maneuvered with sheer persistence. I asked her what brought her to public health.

“I have been in healthcare classes since high school,” she said. Diane started with classes at the East Valley Institute of Technology, initially thinking she wanted to be an allergist or dietitian. “I have sensory issues with smells and touch and bodily fluids. Mostly at EVIT I learned job skills and medical terminology. I really like medical terminology and am good at it.”

She later went on to volunteer in pediatrics and did an internship at a special needs school.

“Working at the hospital, I met the employees that did community programs. There were two staff who had years of experience in public health. They inspired me. When I found the public health program at NAU online, I was excited because transportation to school was a barrier. I really liked my public health classes, so I guess I finally found the right place with my health interest. I like the idea of education and preventing disease.”

Diane and her twin sister live independently in Phoenix, however, are not able to drive. Reliable transportation has been a concern. Finding an online program was key to her success.

“My associate and bachelor’s degrees took about 16 years, so graduation from NAU was a huge accomplishment for me. The problem now is, I don’t know what to do. I see many jobs online I’d like to do, but the problem is that they are all full time.”

Because of Diane’s support service schedule for her physical and behavioral health, she needs a part time public health position.

“I have anxiety because I really want to do a good job at my job and want to like my job,” she says. It takes patience to work with the special needs population. I need things repeated a lot. I need things written down. I like a quiet environment.  Structure is good. It is important to explain things.”

When I asked Diane what she’d like others working in public health to know about those with autism, she said, “Do not treat me differently. I am just like everyone else, but I learn and process information differently.  We need to find a way that works for everyone with a disability.”

Diane is currently interning for the Special Olympics. “My dream job is to educate the healthcare world about working with patients with disabilities. I would like sensory rooms in healthcare facilities. I designed one for my previous internship. I got my dream internship at Special Olympics Arizona and I continue to be involved with them, but their jobs are full time and require a driver’s license.”

Diane is a voice for those in her community, including adults who have other developmental disabilities. “To change the system there is a lot I would do. There should be supportive affordable housing options. There should be more reliable transportation options such as a reduced price for Uber. It would be easier to access needed support.”

I encourage Diane to stay positive. I know anyone who can be this tenacious to finish her degree and find a way into the field she loves will find a good job. In the meantime, she is teaching me how individuals with disabilities see the world in a different, beautiful, useful light.

Register & Nominate for Our Upcoming Annual AZPHA Awards Event!

Thursday, October 26, 2023

5:00pm – 8:30pm

Outdoor Courtyard at the Maricopa Medical Society
326 E Coronado Rd #101, Phoenix, AZ 85004

Tickets are only $60 and includes a full taco bar from Senor Taco with protein taco fillings plus beans, rice, guacamole, chips, tortillas & additional pre-rolled tacos.

Hosted Bar service by Top Shelf Bartenders includes wine, beer and soft drinks.

Register Today

_________________________

Please take a moment to nominate colleagues here by September 15!

Update on Excess Pandemic-Related Deaths in Arizona

Allan Williams, MPH, PhD

While the death toll from the Covid pandemic is usually measured by Covid deaths, these deaths do not reflect the full impact of the pandemic on mortality. A more complete measure of pandemic-related deaths includes all causes of excess mortality during the pandemic. AZ has had the unfortunate distinction of leading the nation in the percent of excess pandemic-related deaths during 2020 -2022 compared to pre-pandemic levels.

While most of the excess deaths are attributable to the largely preventable high rate of Covid deaths in Arizona, many other causes of death were also elevated during the pandemic. Indeed, the CDC estimates that since 2/1/2020, Arizona has experienced 3,020 excess heart disease deaths, 2,223 excess strokes, 3,307 hypertensive diseases, 3,569 excess cancer deaths, 5,174 excess Alzheimer and dementia deaths, and 1,531 excess diabetes deaths.

For all categories combined, Arizona experienced a 31.6% excess of all cause deaths during the pandemic, while the US experienced a 19.2% excess.

The CDC National Center for Health Statistics (NCHS) has provided frequent updates on the numbers and percent of weekly, monthly, and yearly excess deaths since the start of the pandemic. While 2020 and 2021 death counts are considered “final” and complete counts of deaths, 2022 data is several months away from final status and is still considered provisional although mostly complete.  2023 data is considered both provisional and incomplete due to the lag in completing a death certificate after death, submitting the data to NCHS, and data processing.

Consequently, data for recent weeks undercount observed deaths and would result in underestimates of excess deaths. To address this undercount, NCHS provides “weighted” estimates of deaths that occurred in 2022 and 2023. The weighting factor is applied to the death counts and is based on comparisons between provisional and final deaths during previous years by week, state, and for various lag times.

In the following charts, NCHS weighted estimates of observed death counts were utilized to determine the percent of excess deaths from all causes for both Arizona and the US.

This first chart shows the estimated percent of weekly excess deaths during the pandemic for every week between 02/01/20 and 07/15/23 for Arizona and the US. This chart shows that the peaks in excess death in Arizona were typically much higher than the US peaks.  It also shows that in both AZ and the US, excess deaths have declined dramatically several months into 2023, approaching pre-pandemic levels. NCHS also estimated that there were 40,712 excess deaths in AZ and 1,335,688 excess deaths in the US over that time period.

The second chart shows the overall percent of excess deaths during the pandemic by race and ethnicity. Except for the “Other” race category, the percent of excess deaths significantly exceeded the US percent of excess deaths.

For all categories combined, Arizona experienced a 31.6% excess of all cause deaths during the pandemic, while the US experienced a 19.2% excess.

Editorial Note by Will Humble: Arizona’s terrible (and lethal) performance during the pandemic was not bad luck. It was largely due to former governor Ducey and former ADHS director Christ’s unwillingness to implement well-established interventions to mitigate the spread of the virus. In the summer of 2020, it was the fact they had no enforced mitigation in bars, nightclubs and restaurants – leading to the lethal summer of 2020. The lethal January and February 2021 was also largely due to the lack of mitigation in those environments. The 3rd wave of excess deaths in late 2021 and early 2022 was largely due to the governor’s executive orders that thwarted efforts to improve community vaccination levels (e.g. their ‘vaccine passport executive order).